InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Lundbeck faces antitrust investigation

James Nurton, London

The European Commission has opened an antitrust investigation into drugs company Lundbeck, based on information acquired during its sector enquiry into the pharmaceutical industry

The enquiry, completed last year, investigated alleged abuse of competition law by pharmaceutical companies, leading to delays in market entry of generic medicines.

In particular, the enquiry examined allegations about the evergreening of patents, patent clusters and reverse-payment deals.


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here


Most read articles